doi: 10.1002/BIP.22323 93 KhanY
Monitoring blood glucose levels is paramount, particularly for patients on combination therapy with insulin or sulphonylureas
Her background in longevity medicine, preventive medicine, integrative wellness, and evidence-based metabolic care sets a clinical standard unmatched in the North Fulton region
Elizabeth (Izzy) Montgomery, MPA, is a health policy analyst at ACHI
To maximize long-term success, focus on: Maintaining consistent protein intake (1.4-2.4g/kg body weight) Continuing resistance training to preserve muscle mass Gradually increasing fiber consumption to naturally stimulate your bodys GLP-1 production Establishing consistent sleep and stress management routines Working with a provider for safe transitions Prior to stopping GLP-1 medications, collaborating with your healthcare provider is essential
Liraglutide belongs to a group of drugs known as the glucagon-like peptide I or GLP-I which is hormones that control hunger and insulin levels